Abstract
There is no question that periodic monitoring of glycosylated hemoglobin is useful for documenting the degree of glucose control that has prevailed during an interval of several weeks before the sample is taken, since the glycohemoglobin concentration reflects the time-averaged concentration of glucose within the erythrocyte during that period. Evidence supporting the correlation between glycohemoglobin levels and traditional methods of assessing glucose control in insulin-dependent diabetic patients is abundant.1–5 Correlations are best when multiple glucose measurements over several weeks are analyzed, and are not found when a single blood glucose or 24-hour urine glucose determination is used. A study of 18 counselors with insulin-de- pendent diabetes attending an 8-week camp session found that the percent sugar-free urine test was the best predictor of normal or elevated Hb A1c values, although there was also a significant correlation between Hb A1c and mean preprandial blood glucose concentrations.6 Two earlier studies had also found that Hb A1c correlated highly with glycosuria measured three times per day with Clinitest detection during the preceding 8 weeks.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Gabbay KH, Hasty K, Breslow JL, et al: Glycosylated hemoglobins and long term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab 1977;44:859–864.
Gonnen B, Rubenstein AH, Rochman H, et al: Hemoglobin A1 an indicator of metabolic control of diabetic patients. Lancet 1977;2:734–737.
Koenig RJ, Peterson CM, Kilo C, et al: Hemoglobin Alc as an indicator of the degree of glucose intolerance in diabetes. Diabetes 1976;25:230–232.
Koenig RJ, Peterson CM, Jones RL, et al: The correlation of glucose regulation and hemoglobin Alc in diabetes mellitus. New Engl J Med 1976;295:417–420.
Gonnen B, Rochman H, Rubenstein AH: Metabolic control in diabetic patients: Assessment by hemoglobin A1 values. Metabolism 1979;(suppl I):448–452.
Blanc MH, Barnett DM, Gleason RE, et al: Hemoglobin Alc compared with three conventional measures of diabetes control. Diabetes Care 1981;4:349–353.
Lanoe R, Soria J, Thibult N, et al: Glycosylated hemoglobin concentrations and clinical test results in insulin-dependent diabetes. Lancet 1977;2:1156–1157.
Walinder O, Wibell L, Tuvemo T: Relation between hemoglobin A! and determinations of glucose in diabetics treated with and without insulin. Diabete Metab 1980;6:251–255.
Goldstein DE, Walker B, Rawlings SS, et al: Hemoglobin Alc levels in children and adolescents with diabetes mellitus. Diabetes Care 1980;3:503–507.
Agardh C-D, Tallroth G: Lack of correlation between glycosylated haemoglobin concentrations and number of daily insulin injections: cross sectional study in care of ambulatory diabetes. Br Med J 1985; 291:622.
Mecklenberg RS, Benson EA, Benson JW Jr, et al: Long-term metabolic control with insulin pump therapy. Report of experience with 127 patients. N Engl J Med 1985;313:465–468.
Dahlquist G, Blom L, Bolme P, et al: Metabolic control in 131 juvenile- onset diabetic patients as measured by HbAlc: Relation to age, duration, C-peptide, insulin dose, and one or two insulin injections. Diabetes Care 1982;5:399–403.
Mazze RS, Shamoon H, Pasmantier R, et al: Reliability of blood glucose monitoring by patients with diabetes mellitus. Am J Med 1984;77:211–217.
Citrin W, Ellis GJ, Skyler JS: Glycosylated hemoglobin: A tool in identifying psychological problems. Diabetes Care 1980;3:563–564.
McDermott K, Cooks M, Peterson CM: Patient determined glycosylated hemoglobin measurements: An aid to patient Education. Diabetes Care 1981;4:480–483.
Dunn, PJ, Cole RA, Soeldner JS, et al: Stability of hemoglobin Alc levels on repetitive determination in diabetic outpatients. J Clin Endo Metab 1981;52:1019–1022.
Schultz TA, Lewis SB, Davis JL, et al: Effect of sulfonylurea therapy and plasma glucose levels on hemoglobin Alc in Type II diabetes mellitus. Am J Med 1981;70:373–378.
Turner RC, et al. (a multicenter study): U.K. Prospective Diabetes Study: II. Reduction in HbAlc with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. Diabetes 1985;34:793–798.
Pecoraro RE, Chen MS, Porte D: Glycosylated hemoglobin and fasting plasma glucose in the assessment of outpatient glycemic control in NIDDM. Diabetes Care 1982;5:592–599.
Graf RJ, Halter JB, Porte D: Glycosylated hemoglobin in normal subjects and subjects with maturity onset diabetes. Diabetes 1978;27:834–839.
Dolhofer R, Wieland OH: Glycosylation of serum albumin: Elevated glucosyl albumin in diabetic patients. FEBS Lett 1979;103:282–286.
Dolhofer R, Wieland OH: Increased glycosylation of serum albumin in diabetes mellitus. Diabetes 1980;29:417–422.
Guthrow CE, Morris MA, Day JF, et al: Enhanced nonenzymatic glucosylation of serum albumin in diabetes mellitus. Proc Natl Acad Sei USA 1979;76:4258–4261.
Day JF, Thornburg RW, Thorpe SW, et al: Nonenzymatic glucosylation of rat albumin: Studies in vitro and in vivo. J Biol Chem 1979;254:9394–9400.
Day JF, Ingelbretsen CG, Ingelbretsen WR, et al: Nonenzymatic glucosylation of serum proteins and hemoglobin: Response to changes in blood glucose levels in diabetic rats. Diabetes 1980;29:524–527.
Day JF, Thorpe SR, Baynes JW: Non-enzymatically glucosylated albumin: In vitro preparation and isolation from normal human serum. J Biol Chem 1979;254:595–597.
Dolhofer R, Renner R, Wieland OH: Different behavior of haemoglobin Ala-c and glucosyl-albumin levels during recovery from diabetic ketoacidosis and non-acidotic coma. Diabetologia 1981:21;211–215.
Kemp SF, Creech RH, Horn TR: Glycosylated albumin and transferrin: Short term markers of blood glucose control. J Pediatr 1984; 105:394–398.
McFarland KF, Catalano EW, Day JF, et al: Nonenzymatic glucosylation of serum proteins in diabetes mellitus. Diabetes 1979;28:1011–1014.
Yue DK, Morris K, McLennan S, et al: Glycosylation of plasma protein and its relation to glycosylated hemoglobin in diabetes. Diabetes 1980;29:296–300.
Kennedy AI, Kandell TW, Merimee TJ: Serum protein-bound hexose in diabetes: The effect of glycemic control. Diabetes 1979;28:1006–1010.
Gragnoli G, Tanganelli I, Signorini AM, et al: Nonenzymatic glycosylation of serum protein as an indicator of diabetic control. Acta Diabetol Lat 1982;19:161–166.
Jones IR, Owens DR, Williams S, et al: Glycosylated serum albumin: An intermediate index of diabetic control. Diabetes Care 1983;6:501–503.
Kennedy AL, Mehl TD, Merimee TJ: Nonenzymatically glycosylated serum protein: Spurious elevation due to free glucose in serum. Diabetes 1980;29:413–415.
Rendell M, Kao G, Mecherikunnel P, et al: Use of aminophenylboronic acid affinity chromatography to measure glycosylated albumin levels. J Lab Clin Med 1985;105:63–69.
Willey DG, Rosenthal MA, Caldwell S: Glycosylated haemoglobin and plasma glycoprotein assays by affinity chromatography. Diabetologia 1984;27:56–58.
Mehl TD, Wenzel SE, Russell B, et al: Comparison of two indices of glycemic control in diabetic subjects: Glycosylated serum protein and hemoglobin. Diabetes Care 1983;6:34–39.
Tsuchiya S, Sakurai T, Sekiguchi S-I: Nonenzymatic glucosylation of human serum albumin and its influence on binding capacity of sulfonylureas. Biochem Pharmacol 1984;33:2967–2971.
Shaklai N, Garlick RL, Bunn HF: Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem 1984;259:3812–3817.
Brownlee M, Vlassara H, Cerami A: Measurement of glycosylated amino acids and peptides from urine of diabetic patients using affinity chromatoghraphy. Diabetes 1980;29:1044–1047.
Gragnoli G, Signorini AM, Tanganelli I: Nonenzymatic glycosylation of urinary proteins in Type I (insulin-dependent) diabetes: Correlation with metabolic control and degree of proteinuria. Diabetologia 1984;26:411–414.
Lev-Ran A: glycohemoglobin: Its use in the follow-up of diabetes and diagnosis of glucose intolerance. Arch Intern Med 1981;141:747–749.
Santiago JV, Davis JE, Fisher F: Hemoglobin Alc levels in a diabetes detection program. J Clin Endocrinol Metab 1978;47:578–580.
Dunn PJ, Cole RA, Soeldner JS, et al: Temporal relationship of glycosylated hemoglobin concentrations to glucose control in diabetes. Diabetologia 1979;17:213–220.
Flock EY, Bennett PH, Savage PJ, et al: Bimodality of glycosylated hemoglobin distribution in Pima Indians. Diabetes 1979;28:984–989.
Dods RF, Bolmey C: Glycosylated hemoglobin assay and oral glucose tolerance test compared for detection of diabetes mellitus. Clin Chem 1979;25:764–768.
Simon D, Coignet MC, Thibult N, et al: Comparison of glycosylated hemoglobin and fasting plasma glucose in the detection of diabetes mellitus. Am J Epidemiol 1985; 122:589–593.
Dunn PJ, Cole RA, Soeldner JS, et al: Reproducibility of hemoglobin Alc and sensitivity to various degrees of glucose intolerance. Ann Intern Med 1979;91:390–396.
Lev-Ran A, Vanderlaan WP: Glycohemoglobins and glucose intolerance. JAMA 1979;241:912–914.
Boucher BJ, Welch SG, Beer MS: Glycosylated haemoglobins in the diagnosis of diabetes mellitus and for the assessment of chronic hyperglycemia. Diabetologia 1981;21:34–36.
Kesson CM, Young RE, Talwar D, et al: Glycosylated hemoglobin in the diagnosis of non-insulin dependent diabetes mellitus. Diabetes Care 1982;5:395–398.
Bolli G, Compagnucci P, Cartechini MG, et al: HbA1 in subjects with abnormal glucose tolerance but normal fasting plasma glucose. Diabetes 1980;29:272–277.
Dix D, Cohen P, Kingsley S, et al: Glycohemoglobin and glucose tolerance tests compared as indicators of borderline diabetes. Clin Chem 1979;25:877–879.
Cederholm J, Ronquist G, Wibell L: Comparison of glycosylated hemoglobin with oral glucose tolerance test. Diabete Metab 1984;10:224–229.
Hall PM, Cook JGH, Sheldon J, et al: Glycosylated hemoglobins and glycosylated plasma proteins in the diagnosis of diabetes mellitus and impaired glucose tolerance. Diabetes Care 1984;7:147–150.
Walinder O, Libell L, Tuvemo T: Relation between hemoglobin Alc and determintions of glucose in diabetics treated with and without insulin. Diabete Metabol 1980;6:251–255.
Gomo ZAR: The determination of glucose and glycosylated haemoglobin in a nondiabetic Zimbabwean African population. Ann Clin Biochem 1985;22:362–365.
Soler NG, Frank S: Value of glycosylated hemoglobin measurements after myocardial infarction. JAMA 1981;246:1690–1693.
Schleicher ED, Gerbitz KD, Dolhofer R, et al: Clinical utility of nonenzymatically glycosylated blood proteins as an index of glucose control. Diabetes Care 1984;7:548–558.
Widness JA, Schwartz HC, Kahn CB, et al: Glycohemoglobin in diabetic pregnancy: A sequential study. Am J Obstet Gynecol 1980;136:1024–1029.
Lind T, Cheyne GA: Effect of normal pregnancy upon the glycosylated hemoglobins. Br J Obstet Gynecol 1979;86:210–213.
Kjaergaard J-J, Ditzel J: Hemoglobin Alc as an index of long-term blood glucose regulation in diabetic pregnancy. Diabetes 1979;28:694–696.
Gillmer MDG, Beard RW, Brooks FW, et al: Carbohydrate metabolism in pregnancy. I Diurnal plasma glucose profile in normal and diabetic women. Br Med J 1975;3:399–404.
Schwartz HC, King KC, Schwartz AL, et al: Effects of pregnancy on hemoglobin Alc in normal, gestational diabetic, and diabetic women. Diabetes 1976;25:1118–1122.
Leslie RDG, Pyke Da, John PN, et al: Haemoglobin Al in diabetic pregnancy. Lancet 1978;2:958–959.
Miller JM Jr, Crenshaw C Jr, Welt SI: Hemoglobin Alc in normal and diabetic pregnancy. JAMA 1979;242:2785–2787.
Paulsen EP, Khoury M: Hemoglobin Alc levels in insulin-dependent diabetes mellitus. Diabetes 1976;25:890–896.
Pedersen J, Bojsen-Moller B, Poulsen H: Blood sugar in newborn infants of diabetic mothers. Acta Endocrinol 1954;15:33–36.
Freinkel N: Of pregnancy and progeny. Diabetes 1980;29:1023–1035.
Ogata ES, Freinkel N, Metzger BE, et al: Perinatal islet function in gestational diabetes: Assessment by cord plasma, C-peptide and amniotic fluid insulin. Diabetes Care 1980;3:425–429.
Susa JB, McCormick KL, Widness JA, et al: Chronic heperinsulinemia in the fetal rhesus monkey: Effects on fetal growth and composition. Diabetes 1979;28:1058–1063.
Susa JB, Neave C, Sehgal P, et al: Chronic hyperinsulinemia in the fetal rhesus monkey: Effect of physiologic hyperinsulinemia on fetal growth and composition. Diabetes 1984;33:656–660.
Hill DE: Fetal effects of insulin. Obstet Gynecol Ann 1982;11:133–149.
Susa JB, Widness JA, Hintz R, et al: Somatomedins and insulin in diabetic pregnancies: Effects on fetal macrosomia in the human and rhesus monkey. J Clin Endocrinol Metab 1984;58:1099–1105.
Susa JB, Schwartz R: Effects of hyperinsulinemia in the primate fetus. Diabetes 1985;34(suppl 2):36 41.
Widness JA, Schwartz HC, Thompson D, et al: Glycohemoglobin (Hb Alc): a predictor of birth weights in infants of diabetic mothers. J Pediatr 1978;92:8–12.
Baxi L, Barad D, Reece EA, et al: Use of glycosylated hemoglobin as a screen for macrosomia in gestational diabetes. Obstet Gynecol 1984; 64:347–350.
O’Shaughnessy R, Russ, J, Zuspan FP: Glycosylated hemoglobins and diabetes mellitus in pregnancy. Am J Obstet Gynecol 1979;135:783–790.
Sosenko JM, Kitzmiller JL, Fluckiger R, et al: Umbilical cord glycosylated hemoglobin in infants of diabetic mothers: Relationships to neonatal hypoglycemia, macrosimia, and cord serum C-peptide. Diabetes Care 1982;5:566–577.
Madsen H, Ditzel J, Hansen P, et al: Hemoglobin Alc Determinations in diabetic pregnancy. Diabetes Care 1981;4:541–546.
Jovanovic L, Petersen CM: The clinical utility of glycosylated hemoglobin. Am J Med 1981;70:331–338.
Pedersen JF, Molsted-Pedersen L, Mortensen HB: Fetal growth delay and maternal hemoglobin Alc in early diabetic pregnancy. Obstet Gynecol 1984;64:351–352.
Miller E, Hare JW, Cloherty JP, et al: Elevated maternal hemoglobin Alc in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 1981;304:1331–1334.
Ylinen K, Aula P, Stenman UH, et al: Risk of minor and major fetal malformations in diabetics with high haemoglobin Alc values in early pregnancy. Br Med J 1984;289:345–346.
Sosenko IR, Kitzmiller JL, Loo SW, et al: The infant of the diabetic mother. Correlation of increased cord C-peptide levels with macrosomia and hypoglycemia. N Engl J Med 1979;301:859–862.
McFarland KF, Murtiashaw M, Baynes JW: Clinical values of glycosylated serum protein and glycosylated hemoglobin levels in the diagnosis of gestational diabetes mellitus. Obstet Gynecol 1984;64:516–518.
Fadel HE, Hammond SD, Huff TA, et al: Glycosylated hemoglobins in normal pregnancy and gestational diabetes mellitus. Obstet Gynecol 1979;54:322–326.
Chase HP, Glasgow AM: Juvenile diabetes mellitus and serum lipids and lipoprotein levels. Am J Dis Child 1976;130:1113–1117.
Klubjer L, Malnar D, Kardos M, et al: Metabolic control, glycosylated hemoglobin, and high density lipoprotein cholesterol in diabetic children. Eur J Pediatr 1979;132:289–297.
Moore WV, Knapps J, Kauffmann Rl, et al: Plasma lipid levels in insulin- dependent diabetes mellitus. Diabetes Care 1979;2:31–34.
Nikkila EA, Hormila P: Serum lipids and lipoproteins in insulin-treated diabetes. Diabetes 1976;27:1078–1086.
Peterson CM, Koenig RJ, Jones RL, et al: Correlation of serum triglyceride levels and HbAlc concentrations in diabetes mellitus. Diabetes 1977;26:507–509.
Sosenko JM, Breslow JL, Muttinew OS, et al: Hyperglycemia and plasma lipid levels: A prospective study of young insulin-dependent diabetic patients. N Engl J Med 1980;302:650–654.
Aleyassine H, Gardiner RJ, Tonks DB, et al: Glycosylated hemoglobin in diabetes mellitus: Correlations with fasting plasma glucose, serum lipids and glycosuria. Diabetes Care 1980;3:508–514.
Elkeles RJ, Wu J, Hambley J: Hemoglobin At blood glucose and high density lipoprotein cholesterol in insulin requiring diabetes. Lancet 1978;2:547–548.
Calvert GD, Graham JJ, Mannick T, et al: Effects of therapy on plasma high-density lipoprotein-cholesterol concentration in diabetes mellitus. Lancet 1978;2:66–68.
Kennedy AI, Lappin TRJ, Lavery TD, et al: Relation of high density lipoprotein cholesterol concentration to type of diabetes and its control. Br Med J 1978;2:1191–1194.
Lopes-Virella MFL, Stone PG, Colwell JA: Serum high density lipoprotein in diabetic patients. Diabetologia 1977;13:285–291.
Petersen CM, Jones Rl, Esterly JA, et al: Changes in basement membrane thickening and pulse volumes concomitant with improved glucose control and exercise in patients with insulin-dependent diabetes mellitus. Diabetes Care 1980;3:586–589.
Raskin P, Pietri AO, Unger R, et al: The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients with Type I diabetes mellitus. N Engl J Med 1983;309:1546–1550.
Sosenko JM, Miettinen OS, Williamson JR, Gabbay KH: Muscle capillary basement membrane thickness and long-term glycemia in Type I diabetes mellitus. N Engl J Med 1984;311:694–698.
Coller BS, Frank RN, Milton RC, Gralnick HR: Plasma cofactors of platelet function: Correlation with diabetic retinopathy and hemoglobin A1a-c. Ann Intern Med 1978;88:311–316.
Williams JH, Hillson RM, Bron A, et al: Retinopathy is associated with higher glycemia in maturity-onset diabetes. Diabetologia 1984;27:198–202.
White NJ, Waltman SR, Krupin T, et al: Reversal of early ocular abnormalities in juvenile diabetics (IDD) after normalization of hemoglobin Alc. Clin Res 1981;462A.
Graf RJ, Halter JB, Halar E, et al: Nerve conduction abnormalities in untreated maturity-onset diabetes: Relation to levels of fasting plasma glucose and glycosylated hemoglobin. Ann Intern Med 1979;90:298–303.
Wiseman MJ, Saunders AJ, Keen H, et al: Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin- dependent diabetes. N Engl J Med 1985;312:617–621.
Lubec G, Legenstein E, Pollack A, et al: Glomerular basement membrane changes, HbAlc and urinary excretion of acid glycosaminoglycans in children with diabetes mellitus. Clin Chim Acta 1980;103:45–49.
Lyons TJ, Kennedy L: nonenzymatic glycosylation of skin collagen in patients with Type I (insulin-dependent) diabetes mellitus and limited joint mobility. Diabetologia 1985;28:2–5.
Vogt BW, Schleicher ED, Wieland OH: e-amino-lysine-bound glucose in human tissues obtained at autopsy: Increase in diabetes mellitus. Diabetes 1982;31:1123–1127.
Oimomi M, Hatanaka H, Ishikawa K, et al: Increased fructose-lysine of nail protein in diabetic patients. Klin Wochenschr 1984;62:477–478.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Cohen, M.P. (1986). Clinical Use. In: Diabetes and Protein Glycosylation. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4938-2_4
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4938-2_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-9366-8
Online ISBN: 978-1-4612-4938-2
eBook Packages: Springer Book Archive